Cynvenio Bio Gains CLIA Certification for NGS Lab | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer diagnostics company Cynvenio Biosystems announced today its sequencing laboratory has received CLIA certification.

As a result, the lab, located in Westlake Village, Calif., can accept clinical samples from most of the US. In April the company received licensure to accept clinical samples from California, one of the states that require other regulatory approval in addition to CLIA certification before a lab offering an LDT can accept patient samples from the state.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.